-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
DekaBank Deutsche Girozentrale Purchases New Shares in Centogene (NASDAQ:CNTG)
DekaBank Deutsche Girozentrale Purchases New Shares in Centogene (NASDAQ:CNTG)
DekaBank Deutsche Girozentrale bought a new stake in shares of Centogene (NASDAQ:CNTG – Get Rating) in the 1st quarter, HoldingsChannel reports. The fund bought 16,319 shares of the company's stock, valued at approximately $67,000.
Separately, Acadian Asset Management LLC boosted its stake in Centogene by 16.2% in the 4th quarter. Acadian Asset Management LLC now owns 70,725 shares of the company's stock worth $366,000 after purchasing an additional 9,854 shares during the period.
Get Centogene alerts:Analyst Ratings Changes
Separately, SVB Leerink lowered their price target on Centogene from $10.00 to $6.00 and set an "outperform" rating on the stock in a report on Monday, July 18th.
Centogene Trading Down 17.2 %
NASDAQ CNTG opened at $1.59 on Tuesday. The company has a quick ratio of 2.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.67. Centogene has a twelve month low of $1.46 and a twelve month high of $11.75. The firm has a market capitalization of $31.58 million, a PE ratio of -0.66 and a beta of -0.95. The stock's 50 day moving average is $2.45 and its 200 day moving average is $3.44.Centogene (NASDAQ:CNTG – Get Rating) last posted its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. The business had revenue of $11.59 million during the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. Research analysts forecast that Centogene will post -1.72 earnings per share for the current fiscal year.
About Centogene
(Get Rating)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Read More
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- Taking a Look at Nvidia's Stock Amidst The Semiconductor Chip Gut
- Palantir Stock is Showing Signs of Life
- The Institutions Like The Color Of PPG Industries
- What Investors Need to Know to Beat the Market
- Alcoa Is Well-Positioned For 2022 and 2023
Want to see what other hedge funds are holding CNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centogene (NASDAQ:CNTG – Get Rating).
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
DekaBank Deutsche Girozentrale bought a new stake in shares of Centogene (NASDAQ:CNTG – Get Rating) in the 1st quarter, HoldingsChannel reports. The fund bought 16,319 shares of the company's stock, valued at approximately $67,000.
据HoldingsChannel报道，德意志银行在第一季度购买了Centogene(纳斯达克代码：CNTG-GET Rating)的新股。该基金购买了16,319股该公司股票，价值约6.7万美元。
Separately, Acadian Asset Management LLC boosted its stake in Centogene by 16.2% in the 4th quarter. Acadian Asset Management LLC now owns 70,725 shares of the company's stock worth $366,000 after purchasing an additional 9,854 shares during the period.
另外，Acadian Asset Management LLC在第四季度将其在Centogene的持股增加了16.2%。Acadian Asset Management LLC现在拥有70,725股该公司股票，价值36.6万美元，在此期间又购买了9,854股。
Analyst Ratings Changes
分析师评级发生变化
Separately, SVB Leerink lowered their price target on Centogene from $10.00 to $6.00 and set an "outperform" rating on the stock in a report on Monday, July 18th.
另外，SVB Leerink在7月18日(星期一)的一份报告中将Centogene的目标价从10.00美元下调至6.00美元，并对该股设定了“跑赢大盘”的评级。
Centogene Trading Down 17.2 %
Centogene交易下跌17.2%
Centogene (NASDAQ:CNTG – Get Rating) last posted its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. The business had revenue of $11.59 million during the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. Research analysts forecast that Centogene will post -1.72 earnings per share for the current fiscal year.
Centogene(纳斯达克代码：CNTG-GET Rating)上一次公布季度收益是在7月15日(星期五)。该公司公布了本季度每股收益(0.54美元)。该业务本季度的收入为1159万美元。Centogene的净资产回报率为负134.55%，净利润率为负35.35%。研究分析师预测，Centogene本财年的每股收益将达到1.72美元。
About Centogene
关于Centogene
(Get Rating)
(获取评级)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Centogene N.V.及其子公司专注于罕见疾病，将现实世界的临床和基因或其他数据转换为可操作的信息，供世界各地的患者、医生和制药公司使用。它通过三个部门运作：制药、诊断和新冠肺炎测试。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- Taking a Look at Nvidia's Stock Amidst The Semiconductor Chip Gut
- Palantir Stock is Showing Signs of Life
- The Institutions Like The Color Of PPG Industries
- What Investors Need to Know to Beat the Market
- Alcoa Is Well-Positioned For 2022 and 2023
- 免费获取StockNews.com关于Centogene的研究报告(CNTG)
- 看NVIDIA在半导体芯片肠子里的股票
- Palantir Stock正在显示出生机
- 像PPG行业的颜色一样的机构
- 投资者需要知道什么才能击败市场
- 美国铝业为2022年和2023年做好了准备
Want to see what other hedge funds are holding CNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centogene (NASDAQ:CNTG – Get Rating).
想看看其他对冲基金持有CNTG的哪些股份吗？访问HoldingsChannel.com获取Centogene(纳斯达克：cntg-Get Rating)的最新13F备案和内幕交易。
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
接受《世纪英文报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Centogene和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧